Published in Nat Med on May 25, 2015
Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners. J Biochem (2015) 0.88
MicroRNAs in multiple myeloma and related bone disease. Ann Transl Med (2015) 0.81
Progress and Paradigms in Multiple Myeloma. Clin Cancer Res (2016) 0.78
Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells. Oncogene (2016) 0.77
Basigin-2 upregulated by receptor activator of NF-κB ligand enhances lung cancer-induced osteolytic lesions. Cancer Cell Int (2016) 0.75
Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration. Oncotarget (2016) 0.75
Multiple myeloma: Mama, I'm coming home. Nat Rev Cancer (2015) 0.75
Cyclophilin A protects mice against infection by influenza A virus. Sci Rep (2016) 0.75
PKM2 and other key regulators of Warburg effect positively correlate with CD147 (EMMPRIN) gene expression and predict survival in multiple myeloma. Leukemia (2016) 0.75
CD147 functions as the signaling receptor for extracellular divalent copper in hepatocellular carcinoma cells. Oncotarget (2017) 0.75
Selective targeting p53(WT) lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA. Oncogene (2017) 0.75
Wnt/β-catenin signaling and disease. Cell (2012) 16.05
Tumor metastasis: molecular insights and evolving paradigms. Cell (2011) 10.34
How do stem cells find their way home? Blood (2005) 5.13
AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res (2010) 4.89
Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med (2003) 4.69
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. Nat Med (2010) 4.00
Proteomics: the move to mixtures. J Mass Spectrom (2001) 3.95
HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest (2003) 2.89
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood (2007) 2.76
Molecular mechanisms of novel therapeutic approaches for multiple myeloma. Nat Rev Cancer (2002) 2.42
Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene (2009) 2.27
Molecular pathogenesis of multiple myeloma and its premalignant precursor. J Clin Invest (2012) 2.24
The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactions. Eur J Cancer (2006) 1.98
Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma. Proc Natl Acad Sci U S A (2007) 1.77
CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol (2007) 1.77
Cancer-related issues of CD147. Cancer Genomics Proteomics (2010) 1.74
Improved electrospray ionization efficiency compensates for diminished chromatographic resolution and enables proteomics analysis of tyrosine signaling in embryonic stem cells. Anal Chem (2009) 1.74
Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Res (2009) 1.74
BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells. Cancer Res (2009) 1.74
Drugging Wnt signalling in cancer. EMBO J (2012) 1.63
Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling. Sci Transl Med (2012) 1.54
Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells. Circ Res (2006) 1.52
Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics. Clin Exp Immunol (2010) 1.43
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells. Leukemia (2011) 1.38
Myeloma as a model for the process of metastasis: implications for therapy. Blood (2012) 1.36
Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene (2006) 1.31
Angiogenesis in multiple myeloma. Eur J Cancer (2006) 1.31
Cyclophilin A: a key player for human disease. Cell Death Dis (2013) 1.26
Immortalisation of human bone marrow endothelial cells: characterisation of new cell lines. Eur J Clin Invest (2000) 1.19
Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma. Clin Cancer Res (2009) 1.16
Oncogenomics to target myeloma in the bone marrow microenvironment. Clin Cancer Res (2011) 1.13
Targeting the chemotactic function of CD147 reduces collagen-induced arthritis. Immunology (2008) 1.12
An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid. Nat Commun (2012) 1.11
Syndecan-1 in B lymphoid malignancies. Ann Hematol (2002) 1.07
The many faces of EMMPRIN - roles in neuroinflammation. Biochim Biophys Acta (2010) 0.99
The role of microenvironment in tumor angiogenesis. Genes Nutr (2008) 0.98
Extravasation and homing mechanisms in multiple myeloma. Clin Exp Metastasis (2007) 0.97
Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferation. Leukemia (2012) 0.91
Cyclophilin A (CyPA) induces chemotaxis independent of its peptidylprolyl cis-trans isomerase activity: direct binding between CyPA and the ectodomain of CD147. J Biol Chem (2011) 0.89
Angiogenic switch in multiple myeloma. Hematology (2005) 0.87
Advances in understanding the pathogenesis of autoimmune disorders: focus on chemokines and lymphocyte trafficking. Br J Haematol (2013) 0.83
Treatment of (131)I-labeled anti-CD147 monoclonal antibody in VX2 carcinoma-induced liver tumors. Oncol Rep (2013) 0.80